Reagents needed for research by the critical care medicine department (CCMD).

Ended Awarded Last action

Contract number
75N90022F00066
Awardee
Awarding agency
Obligated
$22,334

Award facts

Contract value 100% obligated
$22,333.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Pleasanton, CA 94588, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institutes of Health Clinical Center issued a BPA call to 10X Genomics, Inc. under an unspecified parent blanket purchase agreement with a ceiling value of $22,333.75 on July 21, 2022. The call procures reagents needed for research by the Critical Care Medicine Department. Performance occurs in Pleasanton, California, with ultimate completion by September 30, 2022. Pricing is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract 75N90022F00066?

75N90022F00066 was awarded to 10X Genomics, Inc. by NIH Clinical Center (National Institutes of Health) on July 21, 2022.

How much is contract 75N90022F00066 worth?

The government has obligated $22,334 on 75N90022F00066.

Is contract 75N90022F00066 an order under another contract?

Yes. 75N90022F00066 is a BPA call under 75N98022A00032, a blanket purchase agreement.

Was contract 75N90022F00066 competed?

The extent of competition for 75N90022F00066 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award